Genflow Biosciences (LON:GENF) Announces Earnings Results

Genflow Biosciences (LON:GENF) posted its earnings results on Tuesday. The company reported GBX (0.08) earnings per share for the quarter, Digital Look Earnings reports. Genflow Biosciences had a negative net margin of 170.64% and a positive return on equity of 332.06%.

Genflow Biosciences Trading Down 2.9%

LON GENF opened at GBX 1.94 on Thursday. The stock has a market cap of £11.00 million, a PE ratio of -5.85 and a beta of 2.29. Genflow Biosciences has a twelve month low of GBX 0.90 and a twelve month high of GBX 3.12. The stock has a fifty day simple moving average of GBX 2.01 and a 200-day simple moving average of GBX 2.08.

About Genflow Biosciences

Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.